Abstract
Human cancers are consequence of mutations in genes that encode proteins involved in the control of cellular homeostasis. Most human cancers are sporadic and gene mutations may be induced by a large number of environmental agents. Cell response to carcinogens is regulated by genes involved in liver metabolism. Variability in liver metabolism has been associated with polymorphisms in genes that code for phase I and phase II detoxification enzymes. These polymorphisms are relatively common in the population and may be associated with a higher risk of developing cancer. Moreover, as carcinogens act inducing changes in the DNA, there is a link between DNA repair genes and cancer susceptibility, such that mutations in these genes are associated with cancer susceptibility. Finally, oncogenes and tumor suppressor genes also can present allelic variants that are not directly imply in cancer development but can modify individual susceptibility to cancer. Here we review the most frequent polymorphisms described in genes involved in carcinogen metabolism, DNA repair and in oncogenes and tumor suppressor genes that have been associated with modification in cancer susceptibility.
Keywords: carcinogen, carcinogen metabolism, oncogene, tumor suppressor gene
Current Genomics
Title: Genetics of Cancer Susceptibility
Volume: 3 Issue: 4
Author(s): Rogelio Gonzalez-Sarmiento
Affiliation:
Keywords: carcinogen, carcinogen metabolism, oncogene, tumor suppressor gene
Abstract: Human cancers are consequence of mutations in genes that encode proteins involved in the control of cellular homeostasis. Most human cancers are sporadic and gene mutations may be induced by a large number of environmental agents. Cell response to carcinogens is regulated by genes involved in liver metabolism. Variability in liver metabolism has been associated with polymorphisms in genes that code for phase I and phase II detoxification enzymes. These polymorphisms are relatively common in the population and may be associated with a higher risk of developing cancer. Moreover, as carcinogens act inducing changes in the DNA, there is a link between DNA repair genes and cancer susceptibility, such that mutations in these genes are associated with cancer susceptibility. Finally, oncogenes and tumor suppressor genes also can present allelic variants that are not directly imply in cancer development but can modify individual susceptibility to cancer. Here we review the most frequent polymorphisms described in genes involved in carcinogen metabolism, DNA repair and in oncogenes and tumor suppressor genes that have been associated with modification in cancer susceptibility.
Export Options
About this article
Cite this article as:
Gonzalez-Sarmiento Rogelio, Genetics of Cancer Susceptibility, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350435
DOI https://dx.doi.org/10.2174/1389202023350435 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced AI Techniques in Big Genomic Data Analysis
The thematic issue on "Advanced AI Techniques in Big Genomic Data Analysis" aims to explore the cutting-edge methodologies and applications of artificial intelligence (AI) in the realm of genomic research, where vast amounts of data pose both challenges and opportunities. This issue will cover a broad spectrum of AI-driven strategies, ...read more
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.
This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that ...read more
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases
Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of ...read more
Integrating Machine Learning with Genome Science: Pioneering Developments and Future Directions
Integrating machine learning (ML) with genome science is driving transformative advancements in fields such as genomics, personalized medicine, and drug discovery. Genomic data is vast and complex, making traditional analysis methods inadequate for uncovering deep insights. Machine learning, particularly deep learning models like convolutional neural networks (CNNs) and recurrent neural ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
Current Medicinal Chemistry Synthesis, Radiosynthesis and Metabolism of 131I-Y-c(CGRRAGGSC)
Anti-Cancer Agents in Medicinal Chemistry Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT
Current Cancer Drug Targets <i>Prunella vulgaris</i> L: Critical Pharmacological, Expository Traditional Uses and Extensive Phytochemistry: A Review
Current Drug Discovery Technologies Angiopoietin-2 Axis Inhibitors: Current Status and Future Considerations for Cancer Therapy
Current Angiogenesis (Discontinued) Molecules from Nature: Modulating the Expression of Estrogen Receptor Genes in Breast Cancer Cells
Current Bioactive Compounds Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome
Current Genomics Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy
Current Drug Targets Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer
Current Neurovascular Research Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy
Current Cancer Drug Targets ELISA-based Protein Arrays: Multiplexed Sandwich Immunoassays
Current Proteomics Combined Cancer Therapy with Non-Conventional Drugs: All Roads Lead to AMPK
Mini-Reviews in Medicinal Chemistry Genetics and Bioenergetics of Mitochondria Influencing the Etiology and Pharmacology of Steroidal Hormones
Current Pharmacogenomics Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Surgical Treatment of Endometriosis
Current Women`s Health Reviews Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials The Involvement of Heat Shock Proteins and Related Molecules in the Resistance to Therapies in Breast and Gynecologic Cancer
Current Cancer Therapy Reviews Electrochemically Driven Supramolecular Interaction of Quinones and Ferrocifens: An Example of Redox Activation of Bioactive Compounds
Current Topics in Medicinal Chemistry